The PK/PD Study of A Single Subcutaneous Injection of SHR-1222 in Healthy Subjects
Status:
Completed
Trial end date:
2020-01-06
Target enrollment:
Participant gender:
Summary
This is a Single Center, Randomized, Double-Blind, Dose Escalation, Placebo Parallel
Controlled Phaseâ… Clinical study to Evaluate the Safety, Tolerability and Pharmacokinetics,
Pharmacodynamics with A Single Subcutaneous Injection of SHR-1222 in Healthy Subjects.
The primary objective of this study is to investigate the safety and tolerability of a range
of subcutaneous SHR-1222 in healthy subjects. Secondary objectives are to determine the
pharmacokinetics (PK) and pharmacodynamics(PD) profile of SHR-1222 in healthy subjects
including assessment of immunogenicity.